Results 1 to 10 of about 117,037 (362)
Safety of proton pump inhibitors [PDF]
Alimentary Pharmacology & Therapeutics, 2000 Helge L. Waldum +2 more
openalex +4 more sources
Critical Care Explorations, 2021 OBJECTIVES:. Histamine-2 receptor antagonists are commonly administered for stress ulcer prophylaxis in critically ill adults and may be associated with delirium development.
Ami Shiddapur, BS +3 more
doaj +1 more source
Regular proton pump inhibitor use and incident dementia: population-based cohort study
BMC Medicine, 2022 Background To examine the association between regular use of proton pump inhibitors and the risk of incident dementia, including dementia subtypes, and whether the association differs between APOE genotypes.
Peidong Zhang +9 more
doaj +1 more source
Proton pump inhibitors and gastroenteritis [PDF]
European Journal of Epidemiology, 2016 An association between proton pump inhibitor (PPI) therapy and bacterial gastroenteritis has been suggested as well as contradicted. The aim of this study was to examine the association between the use of PPIs and occurrence of bacterial gastroenteritis in the prospective Rotterdam Study.
Annelies Verbon +4 more
openaire +3 more sources
Omeprazole-induced and pantoprazole-induced asymptomatic hyponatremia: a case report
Journal of Medical Case Reports, 2020 Background Hyponatremia is the most common electrolyte disorder. Thiazides, antidepressants, antipsychotic drugs, and antiepileptic drugs are well-known causes of hyponatremia. Proton pump inhibitor use is a rare cause of hyponatremia and, when reported,
Isabel J. B. van der Zalm +2 more
doaj +1 more source
Chronic kidney disease (CKD) patients are exposed to more proton pump inhibitor (PPI)s compared to non-CKD patients. [PDF]
PLoS ONE, 2018 BACKGROUND:Proton pump inhibitor use is associated with incident chronic kidney disease, chronic kidney disease progression and end-stage renal disease.
Hee Jeong Lee +8 more
doaj +1 more source
Overuse of proton pump inhibitors [PDF]
Polish Archives of Internal Medicine, 2015 Proton pump inhibitors (PPIs) are currently the most effective drugs inhibiting hydrochloric acid secretion. They have replaced histamine type 2 receptor antagonists in the majority of clinical indications, for example, functional dyspepsia, gastroesophageal reflux disease, or drug‑induced upper gastrointestinal tract injury.
Adam Szeląg +2 more
openaire +2 more sources
Proton pump inhibitor deprescription: A rapid review [PDF]
Brazilian Journal of Pharmaceutical Sciences, 2022 Proton pump inhibitors (PPI) are drugs that suppress gastric acid secretion. Its use, without support from scientific evidence, can contribute to polypharmacy, lead to drug interactions and, in the long term, cause serious adverse reactions.
Renata Rodriguez Imparato +1 more
doaj +1 more source
Cost-utility analysis of imrecoxib compared with diclofenac for patients with osteoarthritis
Cost Effectiveness and Resource Allocation, 2021 Background To estimate the cost -utility of imrecoxib compared with diclofenac, as well as the addition of a proton pump inhibitor to both two treatment strategies, for patients with osteoarthritis, from a Chinese healthcare perspective. Methods A Markov
Xueshan Sun +8 more
doaj +1 more source
Life and Science, 2023 Objective: The objective of this study is to determine the effect of long-term proton pump inhibitor use on serum magnesium levels Study Design: Descriptive cross-sectional study.
Fuad Ahmad Siddiqi +5 more
doaj +1 more source